TE_438
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2c_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.06 |
| Counts of samples | TCGA_tumor:37; TCGA_normal:12; GTEx:735 |
| TSS | chr1(-):37152535 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_438.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):37102481,37102501,37103542,37103878,37152432,37152536 |
| teRNA_438.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):37126827,37126847,37149262,37149424,37152432,37152536 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
